| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $73.1M | — | +6.7% |
| Cost of Revenue | $24.2M | — | +10.9% |
| Gross Profit | $48.9M | — | +4.8% |
| R&D Expense | $2.2M | — | +1.3% |
| SG&A Expense | $52.0M | — | -8.2% |
| Operating Income | -$6.8M | — | +54.9% |
| Pre-tax Income | -$10.4M | — | +44.6% |
| Income Tax | $256K | — | +255.6% |
| Net Income | -$10.7M | — | +43.5% |
| EPS (Basic) | -$0.16 | — | +46.7% |
| EPS (Diluted) | -$0.16 | — | +46.7% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $49.8M | -7.5% | -26.7% |
| Accounts Receivable | $52.2M | -4.5% | +10.0% |
| Inventory | $24.8M | -8.0% | +147.3% |
| Current Assets | $138.9M | -2.8% | +5.5% |
| Total Assets | $220.6M | -2.3% | +3.4% |
| Current Liabilities | $68.0M | -9.7% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$10.0M | — | +36.3% |
| Capital Expenditures | $415K | — | +30.1% |
| Investing Cash Flow | -$1.7M | — | +9.1% |
| Financing Cash Flow | $7.6M | — | +567.1% |
| Free Cash Flow | -$10.4M | — | +35.0% |
| +21.0% |
| Long-term Debt | $156.4M | +7.1% | +28.4% |
| Total Liabilities | $249.4M | +0.2% | +13.4% |
| Stockholders' Equity | -$28.8M | -24.6% | -335.8% |